The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Solpadol Caplets 500 mg/30 mg Tablets

Opella Healthcare France SAS T/A SanofiPA23180/012/001

Main Information

Trade NameSolpadol Caplets 500 mg/30 mg Tablets
Active SubstancesParacetamol
Codeine phosphate hemihydrate
Dosage FormTablet
Licence HolderOpella Healthcare France SAS T/A Sanofi
Licence NumberPA23180/012/001

Group Information

ATC CodeN02AJ Opioids in combination with non-opioid analgesics
N02AJ06 codeine and paracetamol


License statusAuthorised
Licence Issued26/06/1991
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceCONTAINS PARACETAMOL Do not take any other Paracetamol containing products. Immediate medical advice should be sought in the event of overdosage even if you feel well. Please read the enclosed leaflet carefully. Consult your doctor if there is no improvement. Prolonged use except on the doctor’s advice may be harmful. This product should be used only when clearly necessary. Do not exceed the stated dose.
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back